Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Stock

New Million Pound TV Campaign for British Cannabis

by
March 16, 2022
in Stock
0
New Million Pound TV Campaign for British Cannabis
0
SHARES
23
VIEWS
Share on FacebookShare on Twitter

BRITISH CANNABIS has launched a new million pound consumer awareness campaign.

As part of this campaign, their adverts will be featured across some of the UK’s most popular national television networks.

These adverts were conceptualised by the creatives at The TV Agency.

This campaign was created in the style of classic health and beauty advertising, with the goal of “break(ing) down barriers to legal cannabis-derived products”.

According to the organisation, the target of the campaign is “45+ year old, health conscious UK consumers”.

These adverts will be aired on both SKY and Channel 5.

BRITISH CANNABIS Managing Director, David Ralson, celebrated the launch.

He said:  “This is a monumental moment for our industry, as this is the first fully-approved TV advert to use ‘cannabis industry’ terminology, including iconography of the industrial Cannabis sativa L. plant itself, reference to our 100% cannabis-based based formulas and real-life consumers using our products.”

BRITISH CANNABIS Marketing Director, Steve Batchelor, echoed this enthusiasm.

He added: “Whilst the CBD consumer base has grown steadily for the last half-decade and with a lot of market hype in recent years, it has by contrast been very difficult to talk frankly about CBD products in traditional advertising mediums, due to obvious issues.”

BRITISH CANNABIS is registered as CBD Health Foods Ltd.

Their products have been critically acclaimed, winning both the P3 Pharmacy Magazine Most Valuable Product Award and CBD Product of The Year from the Independent Community Pharmacist 2022.

 

Previous Post

Should Government Be Your Stockbroker? Maybe So, Says Bloomberg

Next Post

Regan Acquired by Mark Allen Group

Next Post

Regan Acquired by Mark Allen Group

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021

The Political Business Cycle 50 Years Later

0

0

0

0

The Political Business Cycle 50 Years Later

May 10, 2025

Why Elon Musk Is Right: The Case Against Subsidizing Amtrak

May 10, 2025

The Gold-Silver Ratio

May 10, 2025
Friday Feature: MCP Academy

Friday Feature: MCP Academy

May 9, 2025

Recent News

The Political Business Cycle 50 Years Later

May 10, 2025

Why Elon Musk Is Right: The Case Against Subsidizing Amtrak

May 10, 2025

The Gold-Silver Ratio

May 10, 2025
Friday Feature: MCP Academy

Friday Feature: MCP Academy

May 9, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.